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ABSTRACT 
Objective: To develop a method for the determination of diphenhydramine hydrochloride in syrups.  
Methods: The developed method is based on the active ingredient recovery from the pharmaceutical formulation using a cartridge for selective 
solid phase extraction. This procedure is simple and fast as compared to the methods that require liquid/liquid extraction. Once the sample is eluted 
from the cartridge, it is injected directly into a reversed-phase chromatographic system containing a mixture of acetonitrile: 10 mmol ammonium 
acetate: triethylamine 60:39.5:0.5. 
Results: The proposed method fulfilled the validation parameters (linearity R2
Conclusion: The proposed method proved to be reliable when it was applied in the quantification of diphenhydramine hydrochloride of two 
commercial syrup products. 
>0.99, precision CV<2% and accuracy 98-102%). 
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Diphenhydramine is an antihistamine that is most useful in the 
treatment of acute types of allergies and symptoms of rhinitis, 
itching and conjunctivitis. It has antitussive activity and relieves a 
cough caused by bronchial and laryngeal irritation, common cold or 
inhaled agents [1]. It is also used to prevent and treat kinetosis and 
vertigo and is usually included in commercial products against 
insomnia for its sedative action [1]. 
One of the pharmaceutical dosage forms in which this active 
ingredient is administered is syrup (0.25 g/100 ml). The children 
dosage is 1.25 mg/kg of weight, 4 times a day, whereas the adult 
dose varies from 25 to 50 mg, 3 or 4 times a day [2]. 
There are various methods of analysing different pharmaceutical 
presentations of diphenhydramine hydrochloride by using high-
performance liquid chromatography (HPLC) and capillary 
electrophoresis (CE). In the particular case of syrups, the methods 
often consider just one step of syrup dilution [3-5], which happens 
to be extremely simple and does not require any pre-treatment of 
the sample. However, diphenhydramine has the molar extinction 
coefficient of about 500 l/mol cm (A 1 
1% = 17) [6] at 260 nm, which 
means that, in order to have significant signals at such wavelength, 
relatively high concentrations of the active ingredient are required. 
According to the Beer´s law, the response of a sample in absorbance 
units is proportional to the concentration, the optical path length 
and the extinction coefficient. Therefore, smaller values of extinction 
coefficients mean that a higher concentration of analyte will be 
necessary for a better response at the same optical path length. If the 
analyte concentration is lower than the one required to satisfy an 
adequate response at a certain wavelength, a wavelength with an 
extinction coefficient that is more favourable for determination 
should be selected in accordance with the concentration of the final 
sample dilution. With the methods reported previously [3-5], the 
wavelengths between 210 and 215 nm were lower selective because 
very simple chromophores are detected at such wavelengths. 
The direct method could present variability problems or possible 
interferences in the analytical procedure, depending on the 
formulation. Therefore, samples should be submitted to a pre-
treatment so that clean samples can be achieved and analytical 
equipment maintained in better conditions, attaining better 
concentrations of the active ingredient and smaller interferences in 
the analysis. The method of analysis of diphenhydramine 
hydrochloride in syrups that is reported in Mexican Pharmacopeia 
11th
The solid phase extraction (SPE) has been applied to concentrate 
different types of samples (biological fluids, contaminated waters, 
food, etc [12]), but it has also been very useful in removing 
compounds that interfere in complex matrices [13]. Syrups are very 
complex formulations that usually contain a wide spectrum of 
excipients; a pre-treatment of the formulation by SPE allows 
obtaining samples relatively free of interferences for their further 
analysis by HPLC. Given the advantages of SPE, such as: one-step 
recovery of almost 100% of the analyte, a small amount of solvent 
used and a great variety of sorbents that allow selective extraction of 
compounds, this work proposes a method for determination of 
diphenhydramine hydrochloride in syrups by SPE and HPLC. The 
method was validated in accordance with international criteria [14] 
for drug determination in two commercial syrups. 
 Ed., uses liquid-liquid extractions and subsequently, a 
spectrophotometric analysis at 260 nm [7]. The liquid-liquid 
extraction is a separation method particularly used in liquid 
formulations that has some disadvantages, such as use of toxic 
solvents, need for more than one extraction and the subsequent 
necessity to either evaporate the solvent or, by changing the pH, 
transfer the analyte to the aqueous phase for its measurement [7]. 
Some methods for diphenhydramine analysis propose the extraction 
of a coloured complex formed between the analyte and some dye, 
such as eriochrome black T, bromocresol purple, methyl orange, 
bromocresol green and rose bengal, using organic solvents. These 
methods provide an improved capacity of detection and drug 
selectivity, but their extraction requires the use of an organic solvent 
of the formed complex [8-11]. 
MATERIALS AND METHODS 
Reagents 
Diphenhydramine hydrochloride and lidocaine hydrochloride were 
purchased from Sigma Chemical Company. Triethylamine and 
ammonium acetate, reagent grade, were acquired from Merck, 
Mexico. Acetonitrile and methanol solvents, chromatographic grade, 
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were from J. T. Baker, Mexico and the water utilized in all the cases 
was a chromatographic grade, obtained by using a Simplicity System 
equipment (Millipore Corporation, USA). 
Chromatographic conditions 
A Knauer chromatography system, equipped with a Lab Alliance 
series III isocratic pump was employed together with the variable-
wavelength Spectra-Physics SP450 UV/Vis Detector and Knauer D-
14163 Berlin Num. 78098 Manual Injector. Chromabond HR-XCW 3 
ml/200 mg Macherey-Nagel was used for the extraction of 12-port 
Supelco SPE equipment. Chromatographic separation was 
performed in Agilent Zorbax Eclipse plus C18 
Calibration curves were prepared in a concentration interval from 0.5 to 
1.5 mg/ml with 0.3 mg/ml of lidocaine hydrochloride as an internal 
standard. The chromatography system characteristics were evaluated 
using the calibration curves, prepared in five replicates, of 
diphenhydramine hydrochloride with the internal standard in the 
working interval, whereas the standard solutions were diluted with a 
mixture of eluent and mobile phase equivalent to the final solvent of the 
samples (4:1 eluent: mobile phase). The regression values were 
determined together with the coefficients of variation (CV) of the 
replicates. 
column, 150 × 4.6 mm 
with 3.5 µm particle size. A mixture of acetonitrile: 10 mmol 
ammonium acetate: triethylamine 60:39.5:0.5 v/v/v was employed 
as mobile phase [15]. The separation was performed at a flow rate of 
1 ml/min and the detection, at 260 nm. 
Preparation of sample 
Samples of two brands of diphenhydramine hydrochloride syrups were 
submitted to SPE using lidocaine hydrochloride aqueous solution as 
internal standard (0.6 mg/ml). Syrup volumes equivalent to 7.5 mg of 
drug were diluted with 3 ml of aqueous solution of the internal standard. 
Prior to drug extraction from the syrup sample, the cartridge with 3 ml of 
acetonitrile and 7 ml of distilled water was prepared and the sample 
mixed with an internal standard solution was immediately transferred to 
perform the following washes: 5 ml of distilled water and 7 ml of 
acetonitrile: water 50:50. The cartridge was vacuum dried and the 
sample eluted with 4 ml of ammonia at 5% in acetonitrile. The sample 
was then received in a 5 ml flask and diluted with the mobile phase. 
Finally, 20 µl were injected into the chromatography system. 
Method validation 
The precision of the analytical method was assessed in two different 
products, which were analysed for two days in six replicates, by 
calculating the percentage of recovery of the active ingredient with 
respect to the product labels and their CV. 
Method linearity was performed by measuring different volumes of 
syrup, equivalent to 40, 60, 100, 111 and 133% of the amount 
recommended in the method and by treating these samples in 
accordance with the methodology. The linearity was determined by 
calculating the coefficient of determination (R2
RESULTS 
) between the amount 
of active ingredient added and the amount found in two different 
products. In order to determine the accuracy of the method, the 
recovery was calculated at three concentrations (40, 100 and 133%) in 
three replicates, calculating in all cases the percentage of recovery and 
the 95% confidence interval. The method specificity was determined 
using samples of both commercial products and standard solutions, 
submitted to the same procedure and comparing the spectral analyses 
of the peaks. For the evaluation of the latter parameter, Varian Prostar 
equipment with 330 diode array detector was used. 
Fig. 1 shows the chromatogram of the proposed method. The 
retention time for lidocaine hydrochloride was 4.45 min and for 
diphenhydramine hydrochloride, 6.06 min (relative retention time 
1.36). The sample was added dextromethorphan hydrobromide 
because this drug is frequently added to diphenhydramine syrups. 
The retention time was 7.23 min (relative retention time 1.62). The 
resolution between the three compounds was above 2 and the peaks 
displayed adequate asymmetry factor. 
Method validation 
Fig. 2 exhibits the results of chromatography system linearity. The 
R2
 
 of linear regression was 0.99 and the CV of the response factor 
was below 2%. The CV was below 2% at all concentration levels 
examined. The chromatography system met the validation criteria 
for linearity and precision of the analytic system. 
 
Fig. 1: Typical chromatogram, lidocaine hydrochloride 4.45 min, diphenhydramine 6.05 min, dextromethorphan 7.23 min 
 
 
Fig. 2: Chromatographic system linearity. mean±SD, n=5 
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Table 1 shows the CV obtained for the percentage of recovery in 
one day, which was below 2%. The variation during different 
days was also below 2%. The precision of the method met the 
criteria of the precision and intermediate precision for both 
products. 
The equation of the straight line obtained for the ratio of the 
amount added against the amount found was “y = 1.02x+1.57” 
with a R2
Table 2 presents the results for accuracy, with a percentage of 
average recovery for the three levels of concentration tested of 
99.97% and a confidence interval of 98.63 at 101.31%. Thus, the 
method is considered to be within the parameters of accuracy. 
 of 0.99. The statistical analysis of the regression shows 
a slope non-different from 1 and an intercept non-different from 
zero (fig. 3). 
The spectral analysis of syrup samples showed correspondence 
when compared to spectral analysis of standard samples. 
 
Table 1: Precision and intermediate precision of the method 
 Day 1 Day 2 
Product Recovery Average (%) SD CV (%) Recovery Average (%) SD CV (%) Total CV (%) 










SD: standard deviation (n= 6), CV: coefficient of variation (n=6) 
 
 
Fig. 3: Linearity of the proposed method. mean±SD, n=3 
 
Table 2: Method accuracy 
% added % recovered % of recovery 
40 39.60 99.00 
40 39.33 98.33 
40 39.80 99.50 
100 99.20 99.20 
100 100.67 100.67 
100 102.27 102.27 
133 136.00 102.26 
133 129.33 97.24 
133 134.67 101.25 
CI95% 98.63-101.31 (n=9) 
 CI: 95% confidence interval 
 
DISCUSSION 
Methods that use reactions between different dyes and 
diphenhydramine are based on the formation of a complex between 
anionic dyes and positively charged basic groups in acid medium, 
which results in a coloured complex with strong absorption in the 
visible range of electromagnetic spectrum [8-11]. Although they 
present appropriate parameters of validation, they also exhibit some 
limitations in formulations where active ingredients are mixed with 
diphenhydramine-like basic groups. These active ingredients react 
in a similar way [16] and therefore hinder their individual 
determinations by means of this methodology. 
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Methods for determination of diphenhydramine syrup by HPLC or 
capillary electrophoresis that only require syrup dilution are simple 
and fulfil requirements of validation [3-5]. However, the total 
absence of sample treatment entails injecting smaller or higher 
concentrations of a series of components, such as flavouring agents, 
saccharose or aspartame, acidulates, natural or artificial colours and 
preservatives, into the chromatography system. The presence of 
these components in the analytic sample combined with a lower 
selective detection wavelength (210-215 nm), could present 
interference problems during diphenhydramine determination in 
some formulations. 
In this work, the selective separation of basic compounds from of the 
syrup excipients was achieved. In the sample treatment lidocaine 
hydrochloride (internal standard) was submitted to extraction with 
excellent recovery. Additionally, the recovery for dextromethorphan 
hydrobromide solutions was also evaluated, since this compound is 
frequently considered to be associated with diphenhydramine and 
the cartridge was found to have an excellent behaviour with said 
compound. Once the compounds were recovered and were free of 
syrup components, an excellent chromatographic separation of the 
compounds of interest was achieved at a wavelength with a lower 
possibility of interferences. 
The proposed method represents an alternative for analysing 
diphenhydramine hydrochloride syrup by using an easy and fast 
treatment (less than 5 min) that offers selectivity from the very 
extraction. The SPE is a feasible and simple alternative for treating 
samples of diverse origin that saves several resources (time and 
solvents). The type of cartridge selected in this method was a 
modified polymeric resin made of polystyrene-polydivinylbenzene, 
which by means of sulfonation turns into a selective ion-exchange 
cartridge for basic compounds [13]. Therefore, it allows separating 
selectively the compound of interest and the internal standard from 
the other components of the formulation. 
CONCLUSION 
It is important to choose simpler methods of analysis, whose 
performance is more advantageous and less polluting. The 
appropriate pre-treatment of the samples will always provide a 
reliable analytic result. Despite a broad variety of methods reported 
for different analytes, an alternative characterized by simplicity and 
reliability will always have significant application. 
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